The UK Government has provided guidance on how to prepare for Brexit if there's no deal. These technical notices provide information on issues ranging from batch testing medicines if there's no Brexit deal to ensuring blood and blood products are safe and details of how medicines, medical devices and clinical trials would be regulated if there’s no Brexit deal.
In August, the Department of Health and Social Care (DHSC) published Brexit guidance for pharmaceutical industry and suppliers of medical devices. The Health and Social Care Secretary Matt Hancock wrote 2 letters to industry about contingency plans in the unlikely event of a no-deal Brexit.
In his letter to pharmaceutical companies Matt Hancock asks suppliers to:
In his letter to suppliers of medical devices and clinical consumables he says that:
For more information on ‘no deal’ Brexit and medicines, contact the Department of Health and Social Care (DHSC).